---
document_datetime: 2023-09-21 19:11:43
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/protopy-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: protopy-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 0.9975389
conversion_datetime: 2025-12-27 14:26:31.665061
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Steps taken after granting the Marketing Authorisation For procedures finalised after 1 October 2003 please refer to module 8B.

Subsequent post Marketing Authorisation applications agreed upon are summarised in the table below:

| Scope                                                                     | Application number   | Type of modification 1   | Notification / Opinion issued on 2   | Commission Decision Issued/amen- ded on   |
|---------------------------------------------------------------------------|----------------------|--------------------------|--------------------------------------|-------------------------------------------|
| 61(3) Notification to update the contact details of local representatives | N/0001               | N                        | 06.09.02                             | 08.10.02                                  |
| Minor change of manufacturing process of the active substance             | I/0002               | I                        | 03.10.02                             | authorised N/A                            |
| Change in test procedure of active substance                              | I/0003               | I                        | 03.10.02                             | N/A                                       |
| Change in test procedures of the medicinal product                        | I/0004               | I                        | 03.10.02                             | N/A                                       |
| Change in the address of the marketing authorisation holder               | I/0005               | I                        | 03.10.02                             | 07.11.02                                  |
| Addition of 10 g packsize for Protopy 0.03% and 0.1%.                     | I/0006               | longer I                 | 20.02.03                             | 10.04.03                                  |
| Extension of shelf-life as foreseen at time of authorisation              | I/0007               | I                        | 01.08.03                             | 22.09.03                                  |

<!-- image -->

## Medicinal product no longer authorised local representatives Minor change of manufacturing process of the active substance I/0002 Change in test procedure of active substance I/0003 Change in test procedures of the medicinal product I/0004 Change in the address of the marketing authorisation holder I/0005 Addition of 10 g packsize for Protopy 0.03% and 0.1%. I/0006 Extension of shelf-life as foreseen at time of authorisation I/0007 1

For variations before 1 October 2003 in accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II application.

T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 of 7 November 1996.

N refers to a notification in accordance with Article 61(3) of Council Directive 2001/83/EC of 31 March 1992.

2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification date. The Commission Decision will be amended accordingly.